EXPRESSION OF THE NEUROFIBROMATOSIS-I GENE-PRODUCT, NEUROFIBROMIN, IN BLOOD-VESSEL ENDOTHELIAL-CELLS AND SMOOTH-MUSCLE

被引:75
作者
NORTON, KK
XU, J
GUTMANN, DH
机构
[1] UNIV WASHINGTON,SCH MED,CTR STUDY NERVOUS SYST INJURY,ST LOUIS,MO
[2] UNIV WASHINGTON,SCH MED,DEPT NEUROL,ST LOUIS,MO
[3] UNIV WASHINGTON,SCH MED,DEPT PEDIAT,ST LOUIS,MO
[4] UNIV WASHINGTON,SCH MED,DEPT GENET,ST LOUIS,MO
关键词
BISPECIFIC; CANCER THERAPY; SINGLE CHAIN ANTIBODIES;
D O I
10.1006/nbdi.1995.0002
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Vascular pathology is an underestimated complication of neurofibromatosis 1 (NF1). Manifestations include renovascular stenosis with associated hypertension, cerebrovascular occlusion, visceral ischaemia and aneurysms of smaller arteries. This is illustrated by a woman recently evaluated in our Neurofibromatosis Program who had multiple cerebrovascular and renovascular abnormalities. To determine the contribution of NF1 expression to NF1 vasculopathy, the expression of the NF1 gene product, neurofibromin, was examined in blood vessels. Neurofibromin was detected in the endothelial cell layer of rat cerebral vessels, renal arteries, and aorta by immunohistochemistry. Cultured bovine cerebral endothelial cells were found to express NF1 mRNA by RT-PCR and neurofibromin by Western immunoblotting and immunocytochemistry. Neurofibromin expression was also detected in the smooth muscle layer of the aorta but not of cerebral or renal vessels. The vascular abnormalities of NF1 are reviewed and possible pathogenesis with respect to neurofibromin expression is discussed.
引用
收藏
页码:13 / 21
页数:9
相关论文
共 32 条
  • [1] ABBOTT NJ, 1991, CEREBROVAS BRAIN MET, V3, P39
  • [2] AHLGRENBECKENDO.JA, 1993, BIOCHEM BIOPH RES CO, V197, P1019
  • [3] THE NF1 LOCUS ENCODES A PROTEIN FUNCTIONALLY RELATED TO MAMMALIAN GAP AND YEAST IRA PROTEINS
    BALLESTER, R
    MARCHUK, D
    BOGUSKI, M
    SAULINO, A
    LETCHER, R
    WIGLER, M
    COLLINS, F
    [J]. CELL, 1990, 63 (04) : 851 - 859
  • [4] ABERRANT REGULATION OF RAS PROTEINS IN MALIGNANT-TUMOR CELLS FROM TYPE-1 NEUROFIBROMATOSIS PATIENTS
    BASU, TN
    GUTMANN, DH
    FLETCHER, JA
    GLOVER, TW
    COLLINS, FS
    DOWNWARD, J
    [J]. NATURE, 1992, 356 (6371) : 713 - 715
  • [5] BOYER MJ, 1994, ONCOGENE, V9, P349
  • [6] BROOKS BS, 1987, AM J NEURORADIOL, V8, P178
  • [7] THE PROTEIN PRODUCT OF THE NEUROFIBROMATOSIS TYPE-1 GENE IS EXPRESSED AT HIGHEST ABUNDANCE IN NEURONS, SCHWANN-CELLS, AND OLIGODENDROCYTES
    DASTON, MM
    SCRABLE, H
    NORDLUND, M
    STURBAUM, AK
    NISSEN, LM
    RATNER, N
    [J]. NEURON, 1992, 8 (03) : 415 - 428
  • [8] DEBAULT LE, 1979, IN VITRO CELL DEV B, V15, P473
  • [9] DEBAULT LE, 1981, IN VITRO CELL DEV B, V17, P480
  • [10] ABNORMAL REGULATION OF MAMMALIAN P21(RAS) CONTRIBUTES TO MALIGNANT-TUMOR GROWTH IN VONRECKLINGHAUSEN (TYPE-1) NEUROFIBROMATOSIS
    DECLUE, JE
    PAPAGEORGE, AG
    FLETCHER, JA
    DIEHL, SR
    RATNER, N
    VASS, WC
    LOWY, DR
    [J]. CELL, 1992, 69 (02) : 265 - 273